Literature DB >> 26527170

Roles of lipoprotein receptors in the entry of hepatitis C virus.

Jingya Lyu1, Hitomi Imachi1, Kensaku Fukunaga1, Takuo Yoshimoto1, Huanxiang Zhang1, Koji Murao1.   

Abstract

Infection by hepatitis C virus (HCV), a plus-stranded RNA virus that can cause cirrhosis and hepatocellular carcinoma, is one of the major health problems in the world. HCV infection is considered as a multi-step complex process and correlated with abnormal metabolism of lipoprotein. In addition, virus attacks hepatocytes by the initial attaching viral envelop glycoprotein E1/E2 to receptors of lipoproteins on host cells. With the development of HCV model system, mechanisms of HCV cell entry through lipoprotein uptake and its receptor have been extensively studied in detail. Here we summarize recent knowledge about the role of lipoprotein receptors, scavenger receptor class B type I and low-density lipoprotein receptor in the entry of HCV, providing a foundation of novel targeting therapeutic tools against HCV infection.

Entities:  

Keywords:  CD81; Hepatitis C virus entry; Lipoprotein receptors; Low-density lipoprotein receptor; Scavenger receptor class B type I

Year:  2015        PMID: 26527170      PMCID: PMC4621467          DOI: 10.4254/wjh.v7.i24.2535

Source DB:  PubMed          Journal:  World J Hepatol


  79 in total

Review 1.  Hepatitis C virus entry into hepatocytes: molecular mechanisms and targets for antiviral therapies.

Authors:  Mirjam B Zeisel; Isabel Fofana; Samira Fafi-Kremer; Thomas F Baumert
Journal:  J Hepatol       Date:  2010-11-11       Impact factor: 25.083

2.  High-density lipoprotein is a potential growth factor for adrenocortical cells.

Authors:  Koji Murao; Hitomi Imachi; Wenming Cao; Xiao Yu; Junhua Li; Kazuya Yoshida; Rania A M Ahmed; Kensuke Matsumoto; Takamasa Nishiuchi; Norman C W Wong; Toshihiko Ishida
Journal:  Biochem Biophys Res Commun       Date:  2006-03-29       Impact factor: 3.575

Review 3.  Antiviral actions of interferons.

Authors:  C E Samuel
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

4.  Transient activation of the PI3K-AKT pathway by hepatitis C virus to enhance viral entry.

Authors:  Zhe Liu; Yongjun Tian; Keigo Machida; Michael M C Lai; Guangxiang Luo; Steven K H Foung; Jing-hsiung James Ou
Journal:  J Biol Chem       Date:  2012-10-24       Impact factor: 5.157

5.  The level of CD81 cell surface expression is a key determinant for productive entry of hepatitis C virus into host cells.

Authors:  George Koutsoudakis; Eva Herrmann; Stephanie Kallis; Ralf Bartenschlager; Thomas Pietschmann
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

6.  Polarization restricts hepatitis C virus entry into HepG2 hepatoma cells.

Authors:  Christopher J Mee; Helen J Harris; Michelle J Farquhar; Garrick Wilson; Gary Reynolds; Christopher Davis; Sven C D van IJzendoorn; Peter Balfe; Jane A McKeating
Journal:  J Virol       Date:  2009-04-08       Impact factor: 5.103

7.  Ceramide enrichment of the plasma membrane induces CD81 internalization and inhibits hepatitis C virus entry.

Authors:  Cécile Voisset; Muriel Lavie; François Helle; Anne Op De Beeck; Angéline Bilheu; Justine Bertrand-Michel; François Tercé; Laurence Cocquerel; Czeslaw Wychowski; Ngoc Vu-Dac; Jean Dubuisson
Journal:  Cell Microbiol       Date:  2007-11-02       Impact factor: 3.715

8.  Characterization of fusion determinants points to the involvement of three discrete regions of both E1 and E2 glycoproteins in the membrane fusion process of hepatitis C virus.

Authors:  Dimitri Lavillette; Eve-Isabelle Pécheur; Peggy Donot; Judith Fresquet; Jennifer Molle; Romuald Corbau; Marlène Dreux; François Penin; François-Loïc Cosset
Journal:  J Virol       Date:  2007-05-30       Impact factor: 5.103

9.  Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.

Authors: 
Journal:  Lancet       Date:  2014-12-18       Impact factor: 79.321

Review 10.  The C type lectins DC-SIGN and L-SIGN: receptors for viral glycoproteins.

Authors:  Pierre-Yves Lozach; Laura Burleigh; Isabelle Staropoli; Ali Amara
Journal:  Methods Mol Biol       Date:  2007
View more
  4 in total

Review 1.  Viral Hepatitis and Iron Dysregulation: Molecular Pathways and the Role of Lactoferrin.

Authors:  Romina Mancinelli; Luigi Rosa; Antimo Cutone; Maria Stefania Lepanto; Antonio Franchitto; Paolo Onori; Eugenio Gaudio; Piera Valenti
Journal:  Molecules       Date:  2020-04-24       Impact factor: 4.411

Review 2.  Lipid homeostasis and mevalonate pathway in COVID-19: Basic concepts and potential therapeutic targets.

Authors:  Maria Chiara Proto; Donatella Fiore; Chiara Piscopo; Cristina Pagano; Mario Galgani; Sara Bruzzaniti; Chiara Laezza; Patrizia Gazzerro; Maurizio Bifulco
Journal:  Prog Lipid Res       Date:  2021-04-26       Impact factor: 16.195

Review 3.  Hepatitis C virus and proprotein convertase subtilisin/kexin type 9: a detrimental interaction to increase viral infectivity and disrupt lipid metabolism.

Authors:  Matteo Pirro; Vanessa Bianconi; Daniela Francisci; Elisabetta Schiaroli; Francesco Bagaglia; Amirhossein Sahebkar; Franco Baldelli
Journal:  J Cell Mol Med       Date:  2017-07-18       Impact factor: 5.310

Review 4.  Molecular Interactions between Pathogens and the Circadian Clock.

Authors:  Sailen Barik
Journal:  Int J Mol Sci       Date:  2019-11-20       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.